Characterization of nuclear neurokinin 3 receptor expression in rat brain

Neuroscience

Volumn 196, Issue , 2011, Pages 35-48

  Sladek, C D ^a   Stevens, W ^a   Levinson, S R ^a   Song, Z ^a   Jensen, D D ^b   Flynn, F W ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Caudate; Neurokinin 3 nuclear translocation; Substantia nigra; Supraoptic nucleus; Ventral tegmentum

Indexed keywords

MESSENGER RNA; NEUROKININ 3 RECEPTOR; SENKTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NUCLEUS; BRAIN REGION; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOSOL; GLYCOSYLATION; HYPOTENSION; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; SUPRAOPTIC NUCLEUS; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; BRAIN; CELL LINE, TRANSFORMED; CELL NUCLEUS; CHO CELLS; CRICETINAE; CRICETULUS; EPITOPES; GENE EXPRESSION; HUMANS; HYDRALAZINE; HYPOTENSION; MALE; MOLECULAR IMAGING; PROTEIN TRANSPORT; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-3; SHEEP; SUPRAOPTIC NUCLEUS;

EID: 80054015721     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.044     Document Type: Article

References (48)

1. Achour L., Labbé-Jullié C., Scott M.G., Marullo S. An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol Sci 2008, 29:528-535.
2. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., Kawashima E. Molecular characterisation, expression and localisation of human neurokinin-3 receptor. FEBS Lett 1992, 299:90-95.
3. Ciccocioppo R., Panocka I., Polidori C., Froldi R., Angeletti S., Massi M. Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. Pharmacol Biochem Behav 1998, 61:459-464.
4. De Souza Silva M.A., Mello E.L., Müller C.P., Jocham G., Maior R.S., Huston J.P., Tomaz C., Barros M. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys. Eur J Pharmacol 2006, 536:269-278.
5. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 1996, 364:290-310.
6. Flynn F.W., Smith M.E., Beiber S.L. Differential effects of intraventricular injections of tachykinin NK1 and NK3 receptor agonists on normal and sham drinking of NaCl by sodium-deficient rats. Behav Neurosci 1999, 13:776-786.
7. Friedman Y., Richter A., Raymond R., Loscher W., Nobrega J.N. Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains. Neuroscience 2002, 112:639-645.
8. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
9. Haley G.E., Flynn F.W. Agonist and hypertonic saline-induced trafficking of the NK3-receptors on vasopressin neurons within the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1242-R1250.
10. Handwerger K.E., Gall J.G. Subnuclear organelles: new insights into form and function. Trends Cell Biol 2006, 16:19-26.
11. Harrison T.A., Hoover D.B., King M.S. Distinct regional distributions of NK1 and NK3 neurokinin receptor immunoreactivity in rat brainstem gustatory centers. Brain Res Bull 2004, 63:7-17.
12. Hay D.W., Giardina G.A., Griswold D.E., Underwood D.C., Kotzer C.J., Bush B., Potts W., Sandhu P., Lundberg D., Foley J.J., Schmidt D.B., Martin L.D., Kilian D., Legos J.J., Barone F.C., Luttmann M.A., Grugni M., Raveglia L.F., Sarau H.M. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 2002, 300:314-323.
13. Howe H.E., Somponpun S.J., Sladek C.D. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. J Neurosci 2004, 24:10103-10110.
14. Jans D.A., Hassan G. Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?. Bioessays 1998, 20:400-411.
15. Jans D.A., Hübner S. Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol Rev 1996, 76:651-685.
16. Jelaso A.M., DeLong C. NGF and IL-1beta are co-localized in the developing nervous system of the frog, Xenopus laevis. Int J Dev Neurosci 2005, 23:575-586.
17. Jensen D., Zhang Z., Flynn F.W. Trafficking of tachykinin neurokinin 3 receptor to nuclei of neurons in the paraventricular nucleus of the hypothalamus following osmotic challenge. Neuroscience 2008, 155:308-316.
18. Jensen D.D., Sundstrom K., Flynn F.W. Expression of the nuclear transport protein importin β-1 and its association with the neurokinin 3 receptor in the rat hypothalamus following acute hyperosmotic challenge. Neuroscience 2010, 170:1020-1027.
19. Kiefer P., Acland P., Pappin D., Peters G., Dickson C. Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J 1994, 13:4126-4136.
20. Kinsey C.G., Bussolati G., Bosco M., Kimura T., Pizzorno M.C., Chernin M.I., Cassoni P., Novak J.F. Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med 2007, 11:96-110.
21. Lee D.K., Lanca J., Cheng R., Nguyen T., Ji X.D., Gobeil F., Chemtob S., George S.R., O'Dowd B.F. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 2004, 279:7901-7908.
22. Lessard A., Campos M.M., Neugebauer W., Couture R. Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br J Pharmacol 2003, 138:554-563.
23. Lessard A., Savard M., Gobeil F., Pierce J.P., Pickel V.M. The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area. Synapse 2009, 63:484-501.
24. Lévesque M., Parent R., Parent A. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus. Eur J Neurosci 2006, 23:2760-2772.
25. Liao H.J., Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell 2007, 18:1064-1072.
26. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001, 3:802-808.
27. Massi M., Gentili L., Perfumi M., de Caro G., Schulkin J. Inhibition of salt appetite in the rat following injection of tachykinins into the medial amygdala. Brain Res 1990, 513:1-7.
28. Misteli T. Beyond the sequence: cellular organization of genome function. Cell 2007, 128:787-800.
29. Ni C.Y., Murphy M.P., Golde T.E., Carpenter G. Gamma -secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001, 294:2179-2181.
30. Offterdinger M., Schöfer C., Weipoltshammer K., Grunt T.W. c-erbB-3: a nuclear protein in mammary epithelial cells. J Cell Biol 2002, 157:929-939.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1982, p 10003, Academic Press, Inc, New York, NY.
32. Reilly J.F., Maher P.A. Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J Cell Biol 2001, 152:1307-1312.
33. Rouleau M., Aubin R.A., Poirier G.G. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 2004, 117:815-825.
34. Rycyzyn M.A., Reilly S.C., O'Malley K., Clevenger C.V. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol Endocrinol 2000, 14:1175-1186.
35. Salomé N., Stemmelin J., Cohen C., Griebel G. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils. Pharmacol Biochem Behav 2006, 83:533-539.
36. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J Biol Chem 1990, 265:623-628.
37. Shughrue P.J., Lane M.V., Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 1996, 372:395-414.
38. Smith M.E., Flynn F.W. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist, senktide. J Comp Neurol 2000, 426:413-428.
39. Song Z., Vijayaraghavan S., Sladek C.D. Simultaneous exposure to ATP and phenylephrine induces a sustained elevation in the intracellular calcium concentration in supraoptic neurons. Am J Physiol Regul Integr Comp Physiol 2006, 291:R37-R45.
40. Stachowiak M.K., Maher P.A., Joy A., Mordechai E., Stachowiak E.K. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res Mol Brain Res 1996, 38:161-165.
41. Stoessl A.J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res 1994, 646:13-18.
42. Stoessl A.J., Hill D.R. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide. Brain Res 1990, 534:1-7.
43. Stoessl A.J., Szczutkowski E., Glenn B., Watson I. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions. Brain Res 1991, 565:254-262.
44. Tazawa H., Takahashi S., Zilliacus J. Interaction of the parathyroid hormone receptor with the 14-3-3 protein. Biochim Biophys Acta 2003, 1620:32-38.
45. Wells A., Marti U. Signalling shortcuts: cell-surface receptors in the nucleus. Nat Rev Mol Cell Biol 2002, 3:1-6.
46. Xiao Z., Liu X., Lodish H.F. Importin beta mediates nuclear translocation of Smad 3. J Biol Chem 2000, 275:23425-23428.
47. Yip J., Chahl L.A. Localization of tachykinin receptors and Fos-like immunoreactivity induced by substance P in guinea-pig brain. Clin Exp Pharmacol Physiol 2000, 27:943-946.
48. Zwaagstra J.C., Guimond A., O'Connor-McCourt M.D. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest. Exp Cell Res 2000, 258:121-134.